Lisa A. Hazelwood - Publications

Affiliations: 
National Institutes of Health, Bethesda, MD 
Area:
dopamine receptors, GPCRs, Neuropharmacology, proteomics

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Luderman KD, Conroy JL, Free RB, Southall N, Ferrer M, Sanchez-Soto M, Moritz AE, Willette BKA, Fyfe TJ, Jain P, Titus S, Hazelwood LA, Aube J, Lane JR, Frankowski KJ, et al. Identification of positive allosteric modulators of the D1 dopamine receptor that act at diverse binding sites. Molecular Pharmacology. PMID 30068735 DOI: 10.1124/Mol.118.113175  0.595
2011 Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR, Mateo Y, Alvarez VA. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 126-32. PMID 21209197 DOI: 10.1523/Jneurosci.4287-10.2011  0.572
2011 Sibley D, Hazelwood L, Roof R, Free R, Han Y, Javitch J. Membrane lipid rafts are required for D2 dopamine receptor signaling European Psychiatry. 26: 910-910. DOI: 10.1016/S0924-9338(11)72615-3  0.55
2010 Rankin ML, Hazelwood LA, Free RB, Namkung Y, Rex EB, Roof RA, Sibley DR. Molecular Pharmacology of the Dopamine Receptors Dopamine Handbook. DOI: 10.1093/acprof:oso/9780195373035.003.0006  0.595
2009 Free RB, Hazelwood LA, Sibley DR. Identifying novel protein-protein interactions using co-immunoprecipitation and mass spectroscopy. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 5.28. PMID 19170023 DOI: 10.1002/0471142301.Ns0528S46  0.512
2008 Hazelwood LA, Free RB, Cabrera DM, Skinbjerg M, Sibley DR. Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase. The Journal of Biological Chemistry. 283: 36441-53. PMID 18984584 DOI: 10.1074/Jbc.M805520200  0.639
2008 Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes, Brain, and Behavior. 7: 487-95. PMID 18081710 DOI: 10.1111/J.1601-183X.2007.00384.X  0.605
2007 Free RB, Hazelwood LA, Cabrera DM, Spalding HN, Namkung Y, Rankin ML, Sibley DR. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. The Journal of Biological Chemistry. 282: 21285-300. PMID 17395585 DOI: 10.1074/Jbc.M701555200  0.64
2007 Free RB, Hazelwood LA, Spalding HN, Cabrera DM, Sibley DR. Sorting nexin‐25, a novel member of the dopamine receptor signalplex, up‐regulates D 1 and D 2 dopamine receptor expression in HEK293 cells The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A423-D  0.658
2007 Hazelwood LA, Free RB, Cabrera DM, Neiman J, Quinn S, Sibley DR. Reciprocal modulation of function between the D 1 and D 2 dopamine receptors and the Na + /K + ‐ATPase, a novel member of the dopamine receptor signalplex The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A423  0.652
2004 Hazelwood LA, Sanders-Bush E. His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation. Molecular Pharmacology. 66: 1293-300. PMID 15496511 DOI: 10.1124/mol.66.5.  0.626
2003 Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-ht2 receptors: molecular and genomic diversity. Molecular Interventions. 3: 319-30. PMID 14993464 DOI: 10.1124/Mi.3.6.319  0.658
Show low-probability matches.